About the PREVAIL Network

  • Post author:
  • Post category:

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.

Continue ReadingAbout the PREVAIL Network

How Can We Streamline the Vaccine Development Process?

  • Post author:
  • Post category:

To address the urgency of vaccine development during a pandemic, innovative strategies are implemented across study design, regulatory processes, recruitment process and more. In this e-book, we describe some of those innovations and argue for incorporating these into the fabric of clinical trials — to establish a “new normal.”

Continue ReadingHow Can We Streamline the Vaccine Development Process?

Site Monitoring & Management in a Clinical Trial of a Spatial Repellent for Vector-Borne Disease Control

  • Post author:
  • Post category:

The FHI Clinical project team supported site monitoring, site management and project management to assist the University of Notre Dame investigators achieve a level of rigor not typically required for a non-medical product in their double-blinded, randomized-cluster, placebo-controlled clinical trial of a spatial repellent against mosquitoes for malaria prevention.

Continue ReadingSite Monitoring & Management in a Clinical Trial of a Spatial Repellent for Vector-Borne Disease Control

Rapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

  • Post author:
  • Post category:

Targeted geographic areas for the development of an antimalarial drug by Novartis included malaria-endemic regions in Africa and Asia, and Novartis requested assistance identifying and assessing potential clinical sites for their planned clinical trial. Our team conducted 38 rapid, in-depth, 2.5-day site feasibility assessments in the 18 countries.

Continue ReadingRapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

Providing Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea

  • Post author:
  • Post category:

Data monitoring strategies implemented by our bilingual CRA helped eliminate the backlog to ensure timely database lock in a phase 2 trial for Sanaria's innovative PfSPZ Vaccine for malaria in Equatorial Guinea, an area with limited prior research experience.

Continue ReadingProviding Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea